Rationale and Design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): a Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects After Acute Myocardial Infarction

Auteur : Charles Michael Gibson, John J. P. Kastelein, Adam T. Phillips, Philip E. Aylward, Megan K. Yee, Michal Tendera, Stephen J. Nicholls, Stuart J. Pocock, Shaun G. Goodman, John H. Alexander, A. Michael Lincoff, Christoph Bode, Danielle Duffy, Mark Heise, Gail Berman, Sojaita Jenny Mears, Pierluigi Tricoci, Lawrence I. Deckelbaum, P. Gabriel Steg, Paul M. Ridker, Roxana Mehran

Date de publication : 2021

Éditeur : Universität

Nombre de pages : Non disponible